文档介绍：胰腺癌与胰腺癌进展
2006 Estimated US Cancer Cases*
*Excludes basal and squamous cell skin cancers and in situ carcinomas except urinary bladder.
Source: American Cancer Society, 2006.
Men 720,280
Women 679,510
31% Breast
12% Lung & bronchus
11% Colon & rectum
6% Uterine corpus
4% Non-Hodgkin lymphoma
4% Melanoma of skin
3% Thyroid
3% Ovary
2% Urinary bladder
2% Pancreas
22% All Other Sites
Prostate 33%
Lung & bronchus 13%
Colon & rectum 10%
Urinary bladder 6%
Melanoma of skin 5%
Non-Hodgkin 4% lymphoma
Kidney 3%
Oral cavity 3%
Leukemia 3%
Pancreas 2%
All Other Sites 18%
2006 Estimated US Cancer Deaths*
ONS=Other nervous system.
Source: American Cancer Society, 2006.
Men 291,270
Women 273,560
26% Lung & bronchus
15% Breast
10% Colon & rectum
6% Pancreas
6% Ovary
4% Leukemia
3% Non-Hodgkin lymphoma
3% Uterine corpus
2% Multiple myeloma
2% Brain/ONS
23% All other sites
Lung & bronchus 31%
Colon & rectum 10%
Prostate 9%
Pancreas 6%
Leukemia 4%
Liver & intrahepatic 4% bile duct
Esophagus 4%
Non-Hodgkin 3% lymphoma
Urinary bladder 3%
Kidney 3%
All other sites 23%
流行病学
占全部恶性肿瘤的1-2%
死亡率/发病率=
近年我国城市发病率大幅度上升，死亡率上升到第5位。
多发生在50岁以上，2/3患者>65岁，近年年轻患者明显增加趋势
男女比 -：1
Five-year Relative Survival (%)* during Three Time Periods By Cancer Site
*5-year relative survival rates based on follow up of patients through 2002.
†Recent changes in classification of ovarian cancer have affected 1995-2001 survival rates.
Source: Surveillance, Epidemiology, and End Results Program, 1975-2002, Division of Cancer Control and
Population Sciences, National Cancer Institute, 2005.
Site
1974-1976
1983-1985
1995-2001
All sites 50 53 65
Breast (female) 75 78 88
Colon 50 58 64
Leukemia 34 41 48
Lung and bronchus 12 14 15
Melanoma 80 85 92
Non-Hodgkin lymphoma 47 54 60
Ovary 37 41 45
Pancreas 3 3 5
Prostate 67 75 100